Washington Drug Letter

Oct. 31, 2011 | Vol. 43 No. 43

GMP Issues at Hospira N.C. Plant Bite Into Third-Quarter Earnings

Efforts to resolve lingering manufacturing problems at Hospira’s Rocky Mount, N.C., facility led to a 17 percent earnings loss for the Illinois-based drugmaker in the third quarter.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Sun Recalls Nimodipine, Dampening Its Positive Manufacturing News FDA Lifts Import Alert, Sends Closeout Letter to Dr. Reddy’s Mexico API Plant FDA Lifts Import Alert, Sends Closeout Letter to Dr. Reddy’s Mexico API Plant Hospira’s GMP Issues at N.C. Plant Pinch Third-Quarter Earnings

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.